Rule F. Use the appropriate
5th digit behavior code even if the exact term is not listed
in ICD-O.
Refer to the matrix in Table 20 for the underlying structure
and concept of the morphology codes for terms in ICD-O. In
the first example (A) five terms appear with their morphology
codes. Each of these five terms has the same four-digit morphology
code, M-8140, indicating a neoplasm of glandular origin. "Adenoma,
NOS" is a benign tumor and has the behavior code /0.
"Adenocarcinoma, NOS" is the malignant equivalent
of "adenoma, NOS" and has the behavior code /3.
"Adenocarcinoma in situ" has the appropriate behavior
code /2. "Bronchial adenoma" was originally described
as a benign tumor but was later discovered to be malignant
or potentially malignant. "Bronchial adenoma, NOS"
has therefore been assigned the behavior code /1 to indicate
that it is uncertain whether a particular bronchial adenoma
will behave in a benign or malignant manner. "Metastatic
adenocarcinoma, NOS" has the code M-8140/6. The code
M-8140/9 is also part of the matrix even though it is not
printed in the numerical list or alphabetic index of ICD-O.
If a diagnosis of "adenocarcinoma of lung, uncertain
whether primary or metastatic site" was reported in a
clinical or pathology records, it could be coded to M-8140/9.
It would not be used by cancer registrars who, as previously
explained, normally only include /2 (in situ) and /3 (malignant
neoplasm, primary site) in their registries.
|
Table 20.
Morphology and Behavior Code Matrix
|
| |
Example
A |
Example
B |
Example
C |
| Basic
Cell Type |
8140 |
9000 |
9370 |
| 5th Digit
Behavior Code |
| /0
Benign |
8140/0
Adenoma, NOS |
9000/0
Brenner tumor, NOS
(C56.9) |
9370/0 |
| /1
Uncertain whether benign or malignant |
8140/1
Bronchial adenoma
(C34._) |
9000/1
Brenner tumor, borderline malignancy (C56.9) |
9370/1 |
| /2
In situ; non-invasive |
8140/2
Adenocarcinoma in situ |
9000/2 |
9370/2 |
| /3
Malignant, primary |
8140/3
Adenocarcinoma, NOS |
9000/3
Malignant Brenner tumor (C56.9) |
9370/3
Chordoma |
| /6
Malignant, metastatic* |
8140/6
Adenocarcinoma, metastatic |
9000/6 |
9370/6 |
| /9
Malignant, uncertain whether primary or metastatic* |
8140/9 |
9000/9 |
9370/9 |
|
*Not used by cancer registries.
|
|
In the second example (B), three terms are listed under the
four-digit morphology code number M-9000. "Brenner
tumor, NOS" is usually benign, so it
is assigned the code M-9000/0. If a diagnosis of "malignant
Brenner tumor" were reported, however, its correct code
would be M-9000/3; similarly a diagnosis of "Brenner
tumor, borderline malignancy" would be correctly coded
M-9000/1. The codes M-9000/2, M-9000/6, and M-9000/9 have
not been listed in ICD-O. They are available for use when
appropriate; for example, M-9000/2 would be used for "Brenner
tumor in situ" if such an entity were to be identified.
In the third example (C) only one term, "chordoma,"
is listed. "Chordoma" is usually considered to be
a malignant neoplasm and is therefore assigned the morphology
code M-9370/3. Other codes in the 9370 matrix also exist and
could be used when appropriate, for example M-9370/0 for "benign
chordoma," even though this term is not actually listed
in ICD-O. It should be noted that some of the possible combinations
probably do not exist or have not been recognized and defined;
a "benign sarcoma" would contradict current concepts
and usage.
Usually a histologic term carries a clear indication of the
likely behavior of the tumor, whether malignant or benign,
and this is reflected in the behavior code assigned to it
in the ICD-O tabular list. Only a few histologic types of
in situ neoplasms are actually listed in ICD-O. The behavior
code /2 could be attached to any of the four-digit codes in
ICD-O if an in situ form of the neoplasm is diagnosed.
It should be emphasized here that the matrix system was designed
to give the pathologist the final say on whether a tumor is
considered to be benign, malignant, in situ, or uncertain
whether malignant or benign.
The behavior code assigned here is what most pathologists
believe is the usual behavior. If the pathologist disagrees
on the ICD-O code assignment or disagrees in a particular
case, he or she can change the behavior code. For example,
Paget disease of the nipple (breast) is a malignant disease
in ICD-O. Recently some pathologists have felt, in the absence
of a demonstrable tumor, it should be considered "in
situ." In this event they should describe the tumor as
"in situ" and code it accordingly.
Remember that ICD-O is a topography and morphology coding
system (in other words, a coded nomenclature), not a system
for coding stage or extent of disease. ICD-O has no relationship
to the TNM classifications of the International Union Against
Cancer (UICC) or the American Joint Committee on Cancer (AJCC).
Coding is based on what the pathologist states. However, if
the behavior is unclear or not stated, code the behavior as
assigned in ICD-O.
|